Express Scripts Prescriptions Fall, Earnings Match Estimates
- Adjusted earnings of $1.57 a share in line with estimates
- Prescriptions more profitable even as volume declines
This article is for subscribers only.
Express Scripts Holding Co. reported second-quarter profit that matched analysts’ estimates as the number of prescriptions the pharmacy benefit manager processed fell.
Profit excluding one-time items was $1.57 a share, the St. Louis-based company said Monday in a statement, equaling the average of analysts’ estimates compiled by Bloomberg. Adjusted prescription claims decreased 1.8 percent to 315.3 million. Revenue fell 0.9 percent to $25.2 billion, below the average estimate of $25.4 billion.